What is Plantago lanceolata used for?

Plantago lanceolata is traditionally used to relieve throat irritation, dry cough, and mucus-associated symptoms of mild bronchitis. Germany's Commission E has approved it for these indications based on traditional use, though no large-scale clinical trials have confirmed efficacy in humans.

What are the active compounds in Plantago lanceolata?

The primary bioactive compounds are mucilage polysaccharides (responsible for throat-coating effects), aucubin (an iridoid glycoside with anti-inflammatory preclinical activity), and acteoside (verbascoside), which demonstrates antioxidant and 5-lipoxygenase inhibitory properties in laboratory studies. These compounds work together to provide the plant's soothing and anti-inflammatory profile.

What is the recommended dosage of Plantago lanceolata?

The German Commission E recommends an average daily dose of 3–6 grams of dried herb for adults, typically prepared as a tea by steeping 1–2 grams in hot water and consuming 3–4 times daily. Liquid extract dosages vary by product concentration, and standardized extract products should be used according to manufacturer guidelines.

Is Plantago lanceolata safe during pregnancy?

There is insufficient clinical safety data to recommend Plantago lanceolata during pregnancy or breastfeeding, and its use is generally not advised in these populations. While no specific teratogenic effects have been documented, the lack of controlled human studies means the risk-benefit profile cannot be adequately assessed.

Does Plantago lanceolata interact with any medications?

Potential interactions are primarily theoretical: the plant contains vitamin K-related compounds that could interfere with anticoagulants like warfarin, and its mucilage content may slow absorption of orally administered drugs if taken simultaneously. To minimize any absorption interference, Plantago lanceolata preparations should be taken at least 30–60 minutes apart from other medications.

What is the evidence quality for Plantago lanceolata's effectiveness?

Plantago lanceolata's use for cough and throat irritation is based primarily on traditional use classification and preclinical evidence rather than robust clinical trials in humans. The expectorant effects are supported by mechanistic studies of its mucilage content, but no large-scale randomized controlled trials have definitively proven efficacy in patients. This means its benefits are recognized by regulatory bodies like the EMA based on historical use patterns, but stronger clinical evidence would be needed to confirm specific therapeutic claims.

Who should avoid Plantago lanceolata, and are there specific populations at risk?

While generally well-tolerated, individuals with known allergies to Plantaginaceae family plants should avoid Plantago lanceolata. People with certain allergic conditions or those taking immunosuppressive medications should consult a healthcare provider before use. Additionally, those with swallowing difficulties should exercise caution due to the mucilage content, which could theoretically affect swallowing dynamics.

How does Plantago lanceolata compare to other herbal cough remedies?

Plantago lanceolata differs from ivy leaf or thyme extracts in that its primary mechanism is local demulcent and mucilage-based soothing rather than active bronchodilation or antimicrobial action. Unlike licorice root, Plantago lanceolata has minimal systemic absorption and works predominantly through topical coating of irritated mucosa. Both are traditional remedies with similar evidence levels, but Plantago lanceolata is specifically recognized by the EMA monograph for respiratory tract irritation support.

Plantago lanceolata

Plantago lanceolata (ribwort plantain) contains mucilage polysaccharides, aucubin (an iridoid glycoside), and acteoside as its primary bioactive compounds. These constituents are thought to coat and soothe irritated mucous membranes in the throat and bronchi, reducing mechanical irritation that triggers coughing.

Category: European Evidence: 2/10 Tier: Traditional

Plantago lanceolata — Hermetica Encyclopedia

Origin & History

Plantago lanceolata L. (ribwort plantain) is a perennial herbaceous plant native to Europe and widely naturalized in temperate regions worldwide. The dried leaves are harvested during flowering and processed into comminuted herbal substance for teas or infusions, belonging to the chemical class of herbal mucilage drugs characterized by polysaccharides as primary constituents.

Historical & Cultural Context

Used in European traditional medicine for at least 30 years (including 15 years within the EU) for respiratory tract diseases with mucus, with documentation in German pharmacopoeias dating back centuries. Historical texts describe applications for expectorant effects, urinary and gastrointestinal issues, hemostasis, and wound healing in folk medicine.

Health Benefits

• Relief of cough and irritated throat (traditional use, no clinical trials) • Support for mucus-related bronchitis symptoms (traditional use only) • Minor mouth and throat inflammation relief (traditional use classification) • Expectorant effects from mucilage content (preclinical evidence only) • Local demulcent action on irritated mucosa (mechanistic studies, no human trials)

How It Works

The mucilage polysaccharides in Plantago lanceolata form a viscous protective film over inflamed epithelial surfaces, physically reducing irritant contact with mucosal receptors involved in cough reflex signaling. Aucubin, an iridoid glycoside, is metabolized by gut flora to aucubigenin, which has demonstrated inhibition of inflammatory mediators including NF-κB activation and COX-2 expression in preclinical models. Acteoside (verbascoside) contributes antioxidant activity by scavenging reactive oxygen species and inhibiting 5-lipoxygenase, potentially reducing leukotriene-driven airway inflammation.

Scientific Research

No human randomized controlled trials, meta-analyses, or pivotal clinical studies are cited in European Medicines Agency assessments for Plantago lanceolata. The herb is classified under 'traditional use only' with insufficient clinical data to establish efficacy under Directive 2001/83/EC, relying instead on historical use spanning at least 30 years in Europe.

Clinical Summary

Plantago lanceolata is approved by Germany's Commission E for catarrhs of the respiratory tract and inflammatory conditions of the oral and pharyngeal mucosa, based primarily on traditional use and pharmacological plausibility rather than controlled clinical trials. No randomized controlled trials with defined sample sizes, dosing protocols, or quantified outcomes have been published specifically on Plantago lanceolata extracts for cough or bronchitis in humans. In vitro and animal studies support anti-inflammatory and mild expectorant properties of its mucilage fraction, but these findings have not been translated into human clinical evidence. The overall evidence base is classified as traditional use, meaning efficacy is plausible but unconfirmed by modern clinical standards.

Nutritional Profile

Plantago lanceolata (ribwort plantain) leaves contain moderate fiber content (approximately 15-20% dry weight), with mucilaginous polysaccharides (notably plantaglucide and arabinogalactans) accounting for 2-6.5% dry weight, serving as the primary bioactive structural component. Protein content is approximately 10-15% dry weight in young leaves, with a favorable amino acid profile including relatively high levels of lysine and threonine. Carbohydrates comprise roughly 40-50% dry weight, with aucubin (an iridoid glycoside) present at 0.3-2.5% dry weight and acteoside (verbascoside, a phenylethanoid glycoside) at 0.5-3.0% dry weight — both considered principal bioactive markers. Tannin content (primarily catechic tannins) ranges from 3-8% dry weight, contributing to astringent properties. Flavonoids are present at approximately 1.5-2.5% dry weight, predominantly luteolin, apigenin, and their glycosides (luteolin-7-glucoside, homoplantaginin). Vitamin C content in fresh leaves is approximately 35-60 mg per 100g fresh weight, though significantly reduced upon drying. Vitamin K1 (phylloquinone) is notably present at approximately 200-400 µg per 100g fresh weight. Mineral content includes potassium (approximately 400-600 mg/100g dry weight), calcium (approximately 1,200-1,800 mg/100g dry weight), magnesium (approximately 200-300 mg/100g dry weight), zinc (approximately 2-4 mg/100g dry weight), and iron (approximately 10-20 mg/100g dry weight). Silicon compounds are present in measurable quantities (~0.5-1.0% dry weight). Chlorogenic acid and neochlorogenic acid are detectable at combined levels of approximately 0.2-0.8% dry weight. Bioavailability note: mucilaginous polysaccharides are largely non-digestible in the upper GI tract, exerting local demulcent effects; iridoid glycosides such as aucubin demonstrate moderate oral bioavailability with hepatic metabolism to catalpol derivatives; polyphenol bioavailability is limited (~5-10%) due to glycosidic binding and tannin complexation, though gut microbiota hydrolysis increases colonic availability.

Preparation & Dosage

For comminuted herbal substance (tea/infusion): Adults and elderly - 2.1g per dose, 3-5 times daily (6.3-10.6g total daily); Children 5-11 years - 1.0g per dose, 3-5 times daily (3-5g total daily). No standardization for active compounds is specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Thyme, Marshmallow root, Licorice root, Ivy leaf, Elderflower

Safety & Interactions

Plantago lanceolata is generally considered well tolerated at traditional doses, with allergic reactions being the most commonly reported adverse effect, particularly in individuals sensitive to Plantaginaceae family plants or those with grass pollen allergies due to cross-reactivity. Individuals taking anticoagulant medications such as warfarin should use caution, as the plant contains vitamin K compounds and acteoside may exert mild platelet-influencing effects, though formal interaction studies are lacking. No specific contraindications are established beyond known hypersensitivity, but use during pregnancy and lactation is not recommended due to insufficient safety data. Patients with existing bowel obstructions should avoid mucilage-containing preparations, as bulking effects may exacerbate this condition.